Special event at Comerica Park promotes
prostate health and cancer awareness, celebrates prostate cancer
survivors and honors the legacy of those who have fought
courageously
DETROIT, July 1, 2024
/PRNewswire/ -- Hundreds of prostate cancer survivors are expected
to fill the stands at Comerica Park on Monday, July 8, when the Barbara Ann Karmanos
Cancer Institute, in partnership with the Detroit Tigers and
McLaren Health Care, the Tigers' official health care system, join
forces to promote prostate cancer awareness. During the fourth
annual Prostate Cancer Awareness Night, fans will have the
opportunity to learn more about prostate cancer screenings, signs
and symptoms as they cheer on the Detroit Tigers against the
Cleveland Guardians. Prostate cancer survivors will be honored
throughout the game, and a Karmanos prostate cancer patient will
throw the ceremonial first pitch.
Gates will open to Comerica Park at 5
p.m., with first pitch scheduled for 6:40 p.m. Spreading prostate cancer awareness,
Comerica Park will be decorated with a blue theme.
"Prostate cancer is a disease that we can screen for and monitor
PSA levels so that we can treat it at an early stage," said
Elisabeth Heath, M.D., FACP, medical
oncologist, leader of the Genitourinary Oncology Multidisciplinary
Team and the Hartman Endowed Chair for Prostate Cancer
Research. "We want to remind men not just to make their annual
doctor's appointment but to show up and talk to their provider
about their risk of developing prostate cancer and the screening
options available to them. Prostate cancer is curable when we find
it early, so delaying present knowledge of your health does not
benefit your health in the future."
The night will be filled with information about prostate cancer
and prevention methods. A special pre-game ceremony will honor nine
prostate cancer survivors who received care at Karmanos locations
throughout the Karmanos Cancer Network. Throughout the
ballpark, Karmanos will provide information about the disease
and the importance of screening and early detection.
"When I have to give a prostate cancer diagnosis, I let my
patients know it's okay. We're going to work together, manage this
treatment plan and tackle it," shared Dr. Heath. "I am so excited
to honor many of my patients at the game who have had to hear those
words but are doing well in their treatment and survivorship. Join
us at Comerica Park and help me celebrate them and your loved ones
who have fought the disease."
Tigers fans who purchase the special Prostate Cancer Awareness
Night ticket package will receive a Tigers game ticket for
July 8 and a "Strike Out Prostate
Cancer" t-shirt with a $5 donation to
support prostate cancer research at Karmanos. Fans may also donate
an additional amount when purchasing tickets to the July 8 game through tigers.com/prostate. A
portion of the proceeds from a special 50/50 ticket raffle will
also be designated to support prostate cancer research at Karmanos.
Additional opportunities to donate will be displayed at the
Karmanos tables. Click here to purchase tickets.
About Prostate Cancer
Second to skin cancer, prostate
cancer is the most common cancer in American people with a
prostate, affecting roughly one in eight during their lifetime. In
2024, the American Cancer Society estimates that 299,010 men will
be diagnosed with the disease. Though most men diagnosed with
prostate cancer do not die – only 1 in 44 succumb to the disease –
prostate cancer is the second leading cause of cancer death in
American men.
This disease is most curable in its early stages, making early
detection key. Karmanos, McLaren and the Detroit Tigers encourage
men to talk with a health care provider about the benefits and
risks of prostate cancer screening through a Prostate Specific
Antigen (PSA) blood test and a Digital Rectal Exam (DRE). People
with a prostate should consider prostate screening at age 50 (age
45 for African Americans and age 40 for men at even higher risk) if
they are at average risk for prostate cancer. Visit
karmanos.org/prostatefacts for more information.
At Karmanos, the Genitourinary Oncology (GU) Multidisciplinary
Team includes surgical oncologists, medical oncologists, radiation
oncologists, radiologists, pathologists, plastic surgeons,
pharmacists, specialized nurse practitioners, dietitians, social
workers, genetic counselors and patient navigators. The team
specializes in and focuses on treating genitourinary cancers,
including prostate cancer, and shares its collective expertise to
create a customized treatment plan for each patient.
If you are diagnosed with prostate cancer, a referral is not
needed to make an appointment with one of the GU experts at
Karmanos. To request an appointment, visit karmanos.org or call
1-800-KARMANOS.
About the Barbara Ann Karmanos Cancer
Institute
Karmanos Cancer Institute is a leader
in transformative cancer care, research and education through
courage, commitment and compassion. The Karmanos vision is a world
free of cancer. As part of McLaren Health Care, Karmanos is the
largest provider of cancer care and research in Michigan. For more than 75 years, the
administrative and research headquarters, along with the premier
specialty cancer hospital, have been located in downtown
Detroit. With 17 network sites,
Karmanos delivers world-renowned care and access to clinical trials
throughout Michigan and northern
Ohio. The National Cancer
Institute recognizes Karmanos as one of the best cancer centers in
the nation with a comprehensive cancer center designation. Its
academic partnership with the Wayne State
University School of Medicine provides the framework for
cancer research and education – defining new standards of care and
improving survivorship. For more information, call 1-800-KARMANOS
(800-527-6266) or visit karmanos.org. Follow Karmanos
on Facebook, Twitter, LinkedIn and YouTube.
About McLaren Health Care
McLaren Health
Care, headquartered in Grand Blanc,
Michigan, is a $6.6 billion,
fully integrated health care delivery system committed to quality,
evidence-based patient care and cost efficiency. The McLaren system
includes 13 hospitals in Michigan,
ambulatory surgery centers, imaging centers, a 640-member employed
primary and specialty care physician network, commercial and
Medicaid HMOs covering more than 732,838 lives in Michigan and Indiana, home health, infusion and hospice
providers, pharmacy services, a clinical laboratory network and a
wholly owned medical malpractice insurance company. McLaren
operates Michigan's largest network of
cancer centers and providers, anchored by the Karmanos Cancer
Institute, a National Cancer Institute-designated comprehensive
cancer centers. McLaren has 28,000 full-, part-time and contracted
employees and more than 113,000 network providers throughout
Michigan, Indiana and Ohio. Learn more at
mclaren.org.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/karmanos-mclaren-detroit-tigers-strike-out-prostate-cancer-302186520.html
SOURCE Karmanos Cancer Institute